CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 34 enrolled
Drug / intervention
Low Dose Contrast (Omnipaque) 40mL +1 moredrug
Likely dose
Low Dose Contrast (Omnipaque) 40mLfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02669784
NCT02669784N/ACompleted
CompareCT.gov

Does Reduction in Contrast Administration Dose in Computed Tomography Arteriograms Degrade Image Quality? A Single Institutional Review of an Ultra-low Contrast Dose Protocol

Milton S. Hershey Medical Center·interventional·Posted Feb 1, 2016·Updated Jun 11, 2019

In Brief

A clinical study evaluating Low Dose Contrast (Omnipaque) 40mL and Low Dose Contrast (Omnipaque) 50 mL for Aortic Aneurysm and 2 related conditions. Completed, enrolled 34 participants across 1 site.

Detailed Summary

The purpose of the study is to determine if the dose of contrast (Omnipaque) administered for Computed Tomography Arteriograms (CTA) can be reduced without degradation of image quality. The hypothesis is that there is no difference in image quality using ultra-low dose contrast in CTA exams compared to routine, standard of care dose exams.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAortic Aneurysm, Contrast Induced Nephropathy, Aortic and Arterial Anomalies
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedFeb 1, 2016
Enrollment StartFeb 1, 2016
Primary CompletionMay 1, 2017
Study CompletionNov 1, 2018
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 10.4 years ago

Interventions

Low Dose Contrast (Omnipaque) 40mLdrug

The patient will be administered a low dose, 40mL of intravenous contrast (Omnipaque) at a rate of 5mL/sec based on the area of the body being scanned (chest versus chest and abdomen versus chest, abdomen and pelvis). This will be compared to the patient's prior examination performed with 100mL of intravenous contrast at a rate of 4mL/sec.

Low Dose Contrast (Omnipaque) 50 mLdrug

The patient will be administered a low dose, 50mL of intravenous contrast (Omnipaque) at a rate of 5mL/sec based on the area of the body being scanned (chest versus chest and abdomen versus chest, abdomen and pelvis). This will be compared to the patient's prior examination performed with 100mL of intravenous contrast at a rate of 4mL/sec.